The UroLift system (NeoTract) is used to perform a prostatic urethral lift, a procedure that is an alternative to current standard surgical interventions such as transurethral resection of the prostate (TURP) and holmium laser enucleation (HoLEP).
 
Status In progress
Process MT
ID number 241

Provisional Schedule

Committee meeting: MTAC 1 16 October 2020
Draft guidance 06 November 2020 - 04 December 2020
Resolution 28 January 2021
Expected publication 10 March 2021

Project Team

Project lead Harriet Unsworth

Email enquiries

Stakeholders

External assessment group CEDAR
Manufacturers Teleflex
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
22 June 2020 Scope published

For further information on how we develop guidance, please see our page about NICE medical technologies guidance